Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1409 of 6351
-
New hope for Crohn's? Real-World study tests IL-23 drugs
Disease control Recruiting nowThe goal of this observational study is to learn about the effectiveness and safety of IL-23 inhibitors in adults with active Crohn's disease in real-world clinical practice. The main questions it aims to answer are: * What proportion of participants achieve clinical remission a…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug trial hopes to thicken skin Disease's fate
Disease control Recruiting nowA Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Phase 2 • Sponsor: Mediar Therapeutics • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a new dental cement ease pain after Tooth-Saving treatment in kids?
Symptom relief OngoingBRIEF SUMMARY The goal of this clinical trial is to learn whether two materials used during pulpotomy treatment can reduce pain after treatment in children with molar-incisor hypomineralization (MIH), deep tooth decay, and irreversible pulpitis in permanent molars. The main que…
Sponsor: Meire Coelho Ferreira • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
New hope for tough myeloma: experimental drug SG2918 enters human trials
Disease control Recruiting nowThe primary objective of this study was to evaluate the safety and tolerability of SG2918 in patients with relapsed/refractory multiple myeloma.
Phase 1/2 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug aims to reverse bone marrow scarring in rare blood cancer
Disease control Recruiting nowWe hypothesize that pacritinib leads to modification of the myelofibrosis (MF) disease phenotype, especially related to BM fibrosis and cytopenias; due potentially to its dual effect as an inhibitor of the JAK and NFκB pathways, through its targets JAK2 and IRAK1 respectively, le…
Phase 2 • Sponsor: Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New pill may help cancer patients avoid chemo delays due to low platelets
Disease control Not yet recruitingThe study consists of five sequential periods: * Screening (≤ 4 weeks) * Correction phase * Maintenance phase (first treatment cycle, Cycle 1) * Observation phase (second treatment cycle, Cycle 2) * Follow-up Eligible subjects are gynaecological-cancer patients who developed ≥ g…
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New blood test aims to cut unnecessary prostate biopsies
Diagnosis Recruiting nowThis prospective observational study will enroll men referred for prostate biopsy due to elevated PSA and/or abnormal digital rectal examination, with or without pre-biopsy MRI. Peripheral blood will be collected prior to biopsy for PROSTest analysis. Biopsy histopathology will s…
Sponsor: Wren Laboratories LLC • Aim: Diagnosis
Last updated Aug 23, 2026 00:00 UTC
-
New implant study tracks Real-World results for rheumatoid arthritis patients
Disease control Not yet recruitingProspective, multicenter, post-market, registry study designed to systematically collect real-world data (RWD) from participants implanted with the SetPoint System \[implanted, vagus-mediated, neuroimmune modulator\] for the treatment of adults with moderately to severely active …
Sponsor: SetPoint Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New injection aims to control tough blood cancers in early trial
Disease control Not yet recruiting(Limit: 5000 characters) The purpose of this phase I clinical study aims to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of SYS6055 Injection in participants with relapsed/refractory B-cell malignancies, and to provide evidence for r…
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New hope for Crohn's patients: drug may stop disease return after surgery
Disease control Not yet recruitingThe goal of this single arm ,non-interventional, prospective, descriptive study is to evaluate the efficacy of guselkumab treatment in preventing endoscopic recurrence of Crohn's Disease in adult participants who have a documented diagnosis of moderate to severe CD and have under…
Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Zapping the brain without surgery: new hope for epilepsy?
Symptom relief Not yet recruitingTemporal interference (TI) stimulation is a new neuromodulation method. Compared with traditional neuromodulation therapy, TI has deep targeting and focusing, and it has been confirmed to modulate sleep, cognition, and movement disorders. Recent study shown that TI stimulation ta…
Sponsor: Xijing Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Could stem cells restore ovarian function? new trial begins
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety, tolerability and efficacy of human umbilical cord mesenchymal stem cell injection (HS\_SW01 cells injection) in patients with Primary Ovarian Insufficiency (POI). Participants will be required to sign the informed consen…
Phase 1/2 • Sponsor: Shenzhen Huishan Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug picankibart aims to treat stubborn hand and foot pustules
Disease control Recruiting now1. Study Design This study is designed as a prospective, single-arm, open-label clinical study. It will be conducted by the Department of Dermatology, the First Affiliated Hospital of Air Force Medical University, and plans to enroll 60 eligible subjects. 2. Study Subjects Inclu…
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study aims to find best drainage technique for gallbladder infections in High-Risk patients
Disease control Recruiting nowThis multicenter, prospective, open-label, randomized controlled trial compares endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) with endoscopic transpapillary gallbladder drainage (EGBS) in poor surgical candidates with acute calculous cholecystitis. Eligible patients…
Sponsor: Aichi Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New drug may shield kidneys in liver cirrhosis patients
Disease control Not yet recruitingRenal dysfunction is a frequent and clinically important complication in cirrhosis, and MASLD/NAFLD is associated with increased risk of incident CKD; however, finerenone has not been specifically studied in MASLD-cirrhosis populations despite proven cardiorenal benefits in diabe…
Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Pesticide exposure may fuel prostate cancer in martinique men
Knowledge-focused Recruiting nowProstate cancer is the most common male cancer in industrialized countries, including France, with over 60,000 new cases each year, and represents the third leading cause of cancer-related death in men. The only known risk factors are age, ethnic origin and family history of pro…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Can we unlock muscle growth in obesity?
Knowledge-focused Recruiting nowIt is well known that individuals living with overweight or obesity are not able to activate skeletal muscle growth processes to the same extent as lean individuals following activities such as weightlifting (resistance exercise) or protein ingestion. However, the underlying cell…
Sponsor: University of Birmingham • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Can a magnetic helmet lift depression? new study investigates
Symptom relief Recruiting nowThe orbitofrontal cortex (OFC), a region involved in emotional regulation, decision making, and reward processing, is a key area linked to antidepressant response. This study tests whether noninvasive stimulation of the OFC using transcranial magnetic stimulation (TMS) can improv…
Sponsor: Subha Subramanian • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Shock therapy at home? new trial tests brain zaps for speech loss
Symptom relief Recruiting nowThe goal of this clinical trial is to learn whether home-based brain stimulation combined with virtual speech-language therapy can improve communication abilities in adults with logopenic variant primary progressive aphasia (lvPPA), a language disorder most often caused by Alzhei…
Sponsor: Maya Henry • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New antibody drug may boost transplant success in tough lymphoma
Disease control Not yet recruitingThis is an investigator-initiated, open-label, single-arm, multicenter, Phase II clinical study. The study is designed to evaluate the safety and potential effectiveness of glofitamab in adults with their disease, diffuse large B-cell lymphoma (DLBCL has either not responded to i…
Phase 2 • Sponsor: American University of Beirut Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC